Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells - PubMed (original) (raw)
Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells
Norihiro Harada et al. Biochem Biophys Res Commun. 2002.
Abstract
TWEAK, a member of the TNF family, induces cell death in some tumor cell lines, but also induces proliferation of endothelial cells and angiogenesis. Recently, fibroblast growth factor-inducible 14 (Fn14) has been identified to be a TWEAK receptor, which may be responsible for the proliferation of endothelial cells and angiogenesis. In this study, we investigated the pro-inflammatory effect of TWEAK on human umbilical vein endothelial cells (HUVEC). We demonstrated that TWEAK could not only induce the proliferation and migration but also upregulate the cell surface expression of adhesion molecules such as ICAM-1 and E-selectin, and induce the secretion of chemokines such as IL-8 and MCP-1 in HUVEC. Moreover, by using an anti-Fn14 mAb that blocks the TWEAK/Fn14 interaction, we demonstrated that Fn14 was constitutively expressed on HUVEC and totally mediated the biological effects of TWEAK on HUVEC. These results indicated that TWEAK could induce pro-inflammatory reactions via Fn14 on HUVEC.
Similar articles
- Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death.
Nakayama M, Ishidoh K, Kojima Y, Harada N, Kominami E, Okumura K, Yagita H. Nakayama M, et al. J Immunol. 2003 Jan 1;170(1):341-8. doi: 10.4049/jimmunol.170.1.341. J Immunol. 2003. PMID: 12496418 - TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor.
Polek TC, Talpaz M, Darnay BG, Spivak-Kroizman T. Polek TC, et al. J Biol Chem. 2003 Aug 22;278(34):32317-23. doi: 10.1074/jbc.M302518200. Epub 2003 Jun 6. J Biol Chem. 2003. PMID: 12794080 - TWEAK/Fn14 promotes pro-inflammatory cytokine secretion in hepatic stellate cells via NF-κB/STAT3 pathways.
Wang A, Zhang F, Xu H, Xu M, Cao Y, Wang C, Xu Y, Su M, Zhang M, Zhuge Y. Wang A, et al. Mol Immunol. 2017 Jul;87:67-75. doi: 10.1016/j.molimm.2017.04.003. Epub 2017 Apr 12. Mol Immunol. 2017. PMID: 28411440 - The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity.
Campbell S, Michaelson J, Burkly L, Putterman C. Campbell S, et al. Front Biosci. 2004 Sep 1;9:2273-84. doi: 10.2741/1395. Front Biosci. 2004. PMID: 15353286 Review. - TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor.
Wiley SR, Winkles JA. Wiley SR, et al. Cytokine Growth Factor Rev. 2003 Jun-Aug;14(3-4):241-9. doi: 10.1016/s1359-6101(03)00019-4. Cytokine Growth Factor Rev. 2003. PMID: 12787562 Review.
Cited by
- Proinflammatory effects of tumour necrosis factor-like weak inducer of apoptosis (TWEAK) on human gingival fibroblasts.
Hosokawa Y, Hosokawa I, Ozaki K, Nakae H, Matsuo T. Hosokawa Y, et al. Clin Exp Immunol. 2006 Dec;146(3):540-9. doi: 10.1111/j.1365-2249.2006.03233.x. Clin Exp Immunol. 2006. PMID: 17100776 Free PMC article. - TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.
Ando T, Ichikawa J, Wako M, Hatsushika K, Watanabe Y, Sakuma M, Tasaka K, Ogawa H, Hamada Y, Yagita H, Nakao A. Ando T, et al. Arthritis Res Ther. 2006;8(5):R146. doi: 10.1186/ar2038. Arthritis Res Ther. 2006. PMID: 16945157 Free PMC article. - TWEAK as a target for therapy in systemic lupus erythematosus.
Leng RX, Pan HF, Qin WZ, Wang C, Chen LL, Tao JH, Ye DQ. Leng RX, et al. Mol Biol Rep. 2011 Jan;38(1):587-92. doi: 10.1007/s11033-010-0144-9. Epub 2010 Apr 1. Mol Biol Rep. 2011. PMID: 20358293 Review. - The role of tumor necrosis factor-like weak inducer of apoptosis in atherosclerosis via its two different receptors.
Liu H, Lin D, Xiang H, Chen W, Zhao S, Peng H, Yang J, Chen P, Chen S, Lu H. Liu H, et al. Exp Ther Med. 2017 Aug;14(2):891-897. doi: 10.3892/etm.2017.4600. Epub 2017 Jun 14. Exp Ther Med. 2017. PMID: 28781615 Free PMC article. - Soluble TWEAK plasma levels as a novel biomarker of endothelial function in patients with chronic kidney disease.
Yilmaz MI, Carrero JJ, Ortiz A, Martín-Ventura JL, Sonmez A, Saglam M, Yaman H, Yenicesu M, Egido J, Blanco-Colio LM. Yilmaz MI, et al. Clin J Am Soc Nephrol. 2009 Nov;4(11):1716-23. doi: 10.2215/CJN.02760409. Epub 2009 Oct 9. Clin J Am Soc Nephrol. 2009. PMID: 19820131 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous